Larson Financial Group’s MBX Biosciences MBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.7K Buy
199
+150
+306% +$9.39K ﹤0.01% 2427
2026
Q2
$2.7K Hold
49
– – ﹤0.01% 3018
2026
Q1
$1.46K Buy
+49
New +$1.67K ﹤0.01% 3056

Other funds holding MBX

Larson Financial Group's MBX Position: Q3 2026 in Review

Larson Financial Group increased its MBX Biosciences (MBX) stake by 306% in Q3 2026, buying an estimated $9.39K and bringing the position to 199 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2427.

Larson Financial Group first reported a position in MBX in Q1 2026 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • Larson Financial Group held 199 shares of MBX Biosciences worth $11.7K as of Q3 2026.
  • Larson Financial Group bought 150 MBX Biosciences shares in Q3 2026, an estimated $9.39K.
  • MBX Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2427 holding.
  • Larson Financial Group first reported a position in MBX Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.